The H2020 Marie-Sklodowska-Curie-Action NANOGENTOOLS aims at developing new methodologies for the identification and control of hazards associated with nanomaterials, ensuring consumer and society safety. It pursues the main objective of generating a common solid knowledge basis arising from the fruitful cross-sectorial synergy between forefront research centers in nanosafety and industry, in a cross-fertilization multidisciplinary approach that will provide new tests and methodologies (or improve existing ones) to assess the long term risks of nanomaterials (NMs) in a rapid and cost effective manner suitable for regulatory inclusion.
NANOGENTOOLS combines genomics (toxicogenomics), proteomics and multidisciplinary science (biophysics, molecular modelling, chemistry, bioinformatics, chemoinformatics) to develop fast in vitro high throughput (HTS) assays, with molecular based computational models for better understanding of the molecular fundamentals of nanotoxicity, and it will initiate the development of online nanosafety assays for use by SMEs during product development.
Project start: January 2016
Project duration: 48 months
Role of BioNanoNet:
BioNanoNet is partner of the NANOGENTOOLS project. BioNanoNet is responsible for the organization of workshops focussing on interlinking the methodologies addressed by NANOGENTOOLS, and their importance as new vehicles for nanosafety assessment. Furthermore, webinars will be carried out and training sessions will be organized throughout the project lifespan, involving participation of all partners in order to discuss and understand the regulatory impact of nanosafety recommendations arising from new methodologies. Moreover, BioNanoNet supports communication and dissemination activities as well as exploitation of the project’s results.
For more details please visit the project website www3.ubu.es/nanogentools.